Recent Tech Transfer Deals (5/06)
This article was originally published in Start Up
Executive Summary
Each month, Start-Up presents a survey of technology transfer deals-licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
You may also be interested in...
Re-Wiring US FDA’s Regulatory Thinking
The efforts to upgrade FDA’s information technology infrastructure may be opening up into an opportunity to reinvent its processes for regulatory decision making.
Congressional Democrats Press US FDA For Transparency In Review Of COVID-19 Vaccines
FDA should have all coronavirus vaccines evaluated by Vaccines and Related Biological Products Advisory Committee before approval, Democratic senators and representatives say; House subcommittee also wants FDA to require 30,000 participants in Phase III trials.
Flutter Over Biocon’s Repurposed Psoriasis Drug For COVID-19 In India
Biocon’s itolizumab gets clearance in India for restricted emergency use in COVID-19 patients, amid some concerns around small study numbers. But company says data are compelling and cites compassionate use substantiation, while partner Equillium expects to pursue a global study under US IND.
Need a specific report? 1000+ reports available
Buy Reports